Advertisement

Topics

Pfizer anchors inflammation hopes in Xeljanz

10:15 EDT 19 Oct 2016 | BioPharmaDive

After a slow launch, the RA drug is picking up speed, leading the big pharma to invest in growing it further. 

Original Article: Pfizer anchors inflammation hopes in Xeljanz

NEXT ARTICLE

More From BioPortfolio on "Pfizer anchors inflammation hopes in Xeljanz"

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...